Johnson & Johnson is sponsoring a clinical trial at the LSU Epilepsy Center in New Orleans where eligible candidates will be 16 years or older and experiencing partial epileptic seizures. Those meeting the additional study criteria and willing to participate will receive either an investigational medication or placebo for 12 weeks as adjunctive treatment in addition to their current anti-epileptic medications. Study visits and study medication costs will be covered by the Sponsor. At the end of the study, there may be an option to extend treatment (with the active drug) for at least 1 year. Anyone interested in getting more detailed study information should e-mail the study coordinator at epicenter@lsuhsc.edu. Please provide your name, e-mail address or telephone number and the study in which you are interested.